Trevena Inc. (TRVN) Review – Making Smarter Decisions

Trevena Inc. (NASDAQ: TRVN) is 91.46% higher on its value in year-to-date trading and has touched a low of $0.46 and a high of $1.90 in the current 52-week trading range. The TRVN stock was last observed hovering at around $1.61 in the recent trading session, with the current loss setting it -0.02% off its average median price target of $4.00 for the next 12 months. It is also 60.25% off the consensus price target high of $4.00 offered by 1 analysts, but current levels are 60.25% higher than the price target low of $4.00 for the same period.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


At last check, trading at $1.59, the stock is 3.26% and 23.10% above its SMA20 and SMA50 respectively. However, with a current trading volume of 0.86 million and changing -1.55% at the moment leaves the stock 75.23% off its SMA200. TRVN registered 56.31% gain for a year compared to 6-month gain of 83.02%. The firm has a 50-day simple moving average (SMA 50) of $1.4506 and a 200-day simple moving average (SMA200) of $0.9379.

The stock witnessed a 21.97% loss in the last 1 month and extending the period to 3 months gives it a 226.84%, and is 7.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.37% over the week and 9.16% over the month.

Trevena Inc. (TRVN) has around 24 employees, a market worth around $178.15M and $0.03M in sales. Distance from 52-week low is 244.57% and -16.80% from its 52-week high.

Trevena Inc. (TRVN) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Trevena Inc. (TRVN) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Trevena Inc. is expected to release its quarterly report on 07/30/2020 and quarterly earnings per share for the current quarter are estimated at -$0.06.The EPS is expected to grow by 35.20% this year, but quarterly earnings will post 4,738.70% year-over-year.

Trevena Inc. (TRVN) Top Institutional Holders

63 institutions hold shares in Trevena Inc. (TRVN), with 3.28M shares held by insiders accounting for 3.06% while institutional investors hold 21.17% of the company’s shares. The shares outstanding are 107.18M, and float is at 105.79M with Short Float at 5.22%. Institutions hold 20.53% of the Float.

The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 3.92 million shares valued at $2.22 million. The investor’s holdings represent 3.65% of the TRVN Shares outstanding. As of Mar 30, 2020, the second largest holder is NEA Management Company, LLC with 3.81 million shares valued at $2.16 million to account for 3.56% of the shares outstanding. The other top investors are Blackrock Inc. which holds 2.63 million shares representing 2.45% and valued at over $1.49 million, while Renaissance Technologies, LLC holds 2.35% of the shares totaling 2.52 million with a market value of $1.43 million.

Trevena Inc. (TRVN) Insider Activity

A total of 2 insider transactions have happened at Trevena Inc. (TRVN) in the last six months, with sales accounting for 1 and purchases happening 1 times.

Trevena Inc. (TRVN): Who are the competitors?

The company’s main competitors (and peers) include Arena Pharmaceuticals Inc. (ARNA) that is trading 9.70% up over the past 12 months. AcelRx Pharmaceuticals Inc. (ACRX) is -59.41% down on the 1-year trading charts. Short interest in the company’s stock has fallen -8.33% from the last report on May 14, 2020 to stand at a total of 5.98 million short shares sold with a short interest ratio of 1.86.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free